0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Emergency preparedness of health facilities and health workers for viral hemorrhagic fevers in Ekiti State, Nigeria [Conference Abstracts] August 15, 2025 by Irene Among
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Safety and tolerability of dexamethasone combined with standard-of-care ribavirin for the treatment of Lassa fever: An open label randomized controlled phase II clinical trial [Conference Abstract] August 15, 2025 by Allan Mwesiga
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Risk factors associated with Lassa fever infection during the 2025 outbreak in Ondo State, Nigeria [Conference Abstract] August 15, 2025 by Ernest Liuta
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Lessons learnt from community engagement in a prospective cohort study on Lassa fever incidence in Edo State, Nigeria [Conference Abstract] August 15, 2025 by Esther Butamanya
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Engaging research naive communities for participation in Lassa fever studies within catchment areas of a tertiary hospital in Nigeria: The discourses and dilemmas [Conference Abstract] August 15, 2025 by Esther Butamanya
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Assessing the effectiveness of Lassa fever contact tracing in Nigeria, 2020-2024: A five-year trend analysis [Conference Abstract] August 15, 2025 by Ernest Liuta
